Bioinformatics · 2018 · 35 citations · 21 references
Life SciencesBioinformaticsCell BiologyCell SignalingComputational BiologySignal TransductionNetwork ModelingSignal Transduction ModelingSignaling NetworksCancer BioinformaticsCancer Signaling Network AnalysisMitogen-activated Protein Kinase SignalingModular Network AnalysisPerturbation AnalysisSignal Transduction Network ModelingSignaling Network ModelingSignalling Systems
Motivation: Intracellular signalling is realized by complex signalling networks, which are almost impossible to understand without network models, especially if feedbacks are involved. Modular Response Analysis (MRA) is a convenient modelling method to study signalling networks in various contexts. Results: We developed the software package STASNet (STeady-STate Analysis of Signalling Networks) that provides an augmented and extended version of MRA suited to model signalling networks from incomplete perturbation schemes and multi-perturbation data. Using data from the Dialogue on Reverse Engineering Assessment and Methods challenge, we show that predictions from STASNet models are among the top-performing methods. We applied the method to study the effect of SHP2, a protein that has been implicated in resistance to targeted therapy in colon cancer, using a novel dataset from the colon cancer cell line Widr and a SHP2-depleted derivative. We find that SHP2 is required for mitogen-activated protein kinase signalling, whereas AKT signalling only partially depends on SHP2. Availability and implementation: An R-package is available at https://github.com/molsysbio/STASNet. Supplementary information: Supplementary data are available at Bioinformatics online.
21
Scott M. Wilhelm, Christopher Carter, LiYa Tang et al. · Cancer Research · 2004 · 4K citations · Full text
Medicine, Oncology, Pharmacology +17
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad, Chong Sun, Sidong Huang et al. · Nature · 2012 · 2.1K citations · Full text
Medicine, Cancer Biology, Oncology +14
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag, Peter Hirth, James Tsai et al. · Nature · 2010 · 1.8K citations
Medicine, Oncology, Pharmacology +14
A comprehensive pathway map of epidermal growth factor receptor signaling
Kanae Oda, Yukiko Matsuoka, Akira Funahashi et al. · Molecular Systems Biology · 2005 · 1.2K citations · Full text